Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.
| Issuer | Shares | Source | Last tx | Detail |
|---|---|---|---|---|
| Assertio Holdings, Inc. | 26,667 | reported | 02 Mar 2026 | tx 5+1,661,642 |
| CANCERVAX CORP | 20,150 | reported | 16 Mar 2011 | tx 34+850,356−789,458 |
| Date | Type | Issuer | Qty | Price | Signals |
|---|---|---|---|---|---|
| 02 Mar 2026 | GRANT_AWARD | Assertio Holdings, Inc. | 26,667 | 0.00 USD | deriv |
| 13 Nov 2025 | GRANT_AWARD | Assertio Holdings, Inc. | 1,000,000 | 0.00 USD | deriv |
| 13 Nov 2025 | GRANT_AWARD | Assertio Holdings, Inc. | 500,000 | 0.00 USD | deriv |
| 02 Jan 2025 | GRANT_AWARD | Assertio Holdings, Inc. | 53,750 | 0.00 USD | |
| 02 Jan 2025 | GRANT_AWARD | Assertio Holdings, Inc. | 81,225 | 0.00 USD | deriv |
| 16 Mar 2011 | EXERCISE | CANCERVAX CORP | 20,150 | 1.98 USD | |
| 16 Mar 2011 | SALE | CANCERVAX CORP | 20,150 | 5.01 USD | |
| 16 Mar 2011 | SALE | CANCERVAX CORP | 19,900 | 5.01 USD | |
| 16 Mar 2011 | EXERCISE | CANCERVAX CORP | 19,900 | 1.75 USD | |
| 16 Mar 2011 | EXERCISE | CANCERVAX CORP | 19,900 | 0.00 USD | deriv |
| 16 Mar 2011 | EXERCISE | CANCERVAX CORP | 20,150 | 0.00 USD | deriv |
| 15 Mar 2011 | SALE | CANCERVAX CORP | 111,100 | 5.11 USD | |
| 15 Mar 2011 | EXERCISE | CANCERVAX CORP | 111,100 | 1.98 USD | |
| 15 Mar 2011 | EXERCISE | CANCERVAX CORP | 90,909 | 0.00 USD | deriv |
| 15 Mar 2011 | EXERCISE | CANCERVAX CORP | 20,191 | 0.00 USD | deriv |
| 01 Mar 2011 | GRANT_AWARD | CANCERVAX CORP | 112,500 | 0.00 USD | deriv |
| 01 Apr 2010 | GRANT_AWARD | CANCERVAX CORP | 135,000 | 0.00 USD | deriv |
| 29 Jan 2010 | GRANT_AWARD | CANCERVAX CORP | 23,333 | 0.00 USD | deriv |
| 12 Jun 2009 | SALE | CANCERVAX CORP | 7,800 | 4.62 USD | |
| 10 Jun 2009 | SALE | CANCERVAX CORP | 91,062 | 4.56 USD | |
| 11 Jun 2009 | EXERCISE | CANCERVAX CORP | 41,442 | 1.98 USD | |
| 10 Jun 2009 | EXERCISE | CANCERVAX CORP | 75,757 | 1.98 USD | |
| 11 Jun 2009 | EXERCISE | CANCERVAX CORP | 4,139 | 1.75 USD | |
| 11 Jun 2009 | EXERCISE | CANCERVAX CORP | 21,429 | 1.75 USD | |
| 11 Jun 2009 | EXERCISE | CANCERVAX CORP | 2,222 | 3.16 USD |